Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Tyra Biosciences, Inc. (TYRA)
USD31.93
-0.95 (-2.89%)
US NASDAQ Healthcare Biotechnology
Address
2656 State Street 92008
Carlsbad, CA, US
Carlsbad, CA, US
CEO
Todd Harris
Website
tyra.bio
IPO
2021-09-15
CIK 1863127 ISIN US90240B1061
Description
Tyra Biosciences, Inc. is a preclinical biopharmaceutical company focused on innovating treatments to tackle tumor resistance and enhance patient outcomes in oncology. Its flagship product candidate, TYRA-300, is a highly selective inhibitor of fibroblast growth factor receptor (FGFR)3, specifically engineered for the treatment of muscle-invasive bladder cancer. Beyond this, the company is advancing a pipeline of programs addressing other critical conditions, including FGFR2-related intrahepatic cholangiocarcinoma, FGFR3-associated achondroplasia, REarranged during transfection (RET) kinase aberrations, and various FGFR4-driven cancers. Tyra also leverages its proprietary SNAP platform, designed to accelerate structural drug design through an iterative molecular 'snapshot' approach. Founded in 2018, Tyra Biosciences maintains its headquarters in Carlsbad, California.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD31.93
-0.95 (-2.89%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
990.7K
Beta
0.75
Float Shares
39.56M
Free Float %
73.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.79% | +9.83% | +1.60% | +29.30% | +132.14% | +37.66% | +262.63% | +174.58% | +39.19% | +39.19% | +39.19% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (7 ratings, all time)
Buy
Price Targets & DCF
Current price
31.93
Low
42.00
+31.5%
Consensus
50.50
+58.2%
Median
51.50
+61.3%
High
59.00
+84.8%
DCF (Unlevered)
1.18
-96.3%
DCF (Levered)
1.20
-96.2%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 11 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
54.00
+69.1%
|
| Last Quarter | 2 |
49.50
+55.0%
|
| Last Year | 8 |
47.00
+47.2%
|
| All Time | 15 |
37.87
+18.6%
|
Quality scores
Altman Z-Score
44.58
Safe zone
Piotroski F-Score
1 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
2 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%-33.1% Q1'26: -36.2% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%-1,335.1% Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+4.2% Q1'26: +4.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.05× Q1'26: -0.03× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 7 Rev. Ana. 11 EPS Ana. |
Dec 2027 9 Rev. Ana. 8 EPS Ana. |
Dec 2028 9 Rev. Ana. 9 EPS Ana. |
Dec 2029 4 Rev. Ana. 3 EPS Ana. |
Dec 2030 4 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
—
|
—
|
687.4K
687.4K – 687.4K
|
1.06M
1.06M – 1.06M
+53.9% YoY
|
10.37M
10.37M – 10.37M
+880.7% YoY
|
46.69M
46.69M – 46.69M
+350.0% YoY
|
235.58M
235.58M – 235.58M
+404.6% YoY
|
| EBITDA |
-103.66M
|
-119.40M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-104.18M
|
-119.95M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-86.48M
est: -89.21M (+3.1%)
|
-119.95M
est: -119.95M (+0.0%)
|
-152.43M
-156.58M – -120.67M
-27.1% YoY
|
-149.99M
-179.75M – -120.23M
+1.6% YoY
|
-203.17M
-203.93M – -66.40M
-35.5% YoY
|
-158.99M
-158.99M – -158.99M
+21.7% YoY
|
-58.39M
-58.39M – -58.39M
+63.3% YoY
|
| SGA |
24.10M
|
29.83M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-1.51
est: -1.55 (+2.8%)
|
-2.01
est: -1.98 (-1.6%)
|
-2.39
-2.63 – -2.02
-20.8% YoY
|
-2.65
-3.02 – -2.02
-10.9% YoY
|
-2.83
-3.42 – -1.11
-6.6% YoY
|
-2.67
-2.67 – -2.67
+5.6% YoY
|
-0.98
-0.98 – -0.98
+63.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-01 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
56
Total invested
289.20M
Insider transactions (90d)
5
Beneficial owners (>5%)
30
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Peter Kolchinsky | 7.24M | 17.00% | — | 7.24M | — | 11.00 | HC, IN | — | 2021-09-27 | ↗ |
| 2 | RA Capital Management, L.P. | 7.24M | 17.00% | — | 7.24M | — | 11.00 | IA, PN | — | 2021-09-27 | ↗ |
| 3 | Boxer Asset Management Inc. | 6.32M | 15.10% | — | 6.32M | — | 6.32M | CO | — | 2022-06-16 | ↗ |
| 4 | Boxer Capital, LLC | 6.32M | 15.10% | — | 6.32M | — | 6.32M | OO | — | 2022-06-16 | ↗ |
| 5 | Joe Lewis | 6.32M | 15.10% | — | 6.32M | — | 6.32M | IN | — | 2022-06-16 | ↗ |
| 6 | RA Capital Healthcare Fund, L.P. | 5.30M | 12.50% | — | 5.30M | — | 10.00 | PN | Delaware | 2021-09-27 | ↗ |
| 7 | Alta Partners NextGen Fund II Management, LLC | 4.08M | 9.60% | — | 4.08M | — | 10.00 | OO | Delaware | 2021-09-27 | ↗ |
| 8 | Alta Partners NextGen Fund II, L.P. | 4.08M | 9.60% | — | 4.08M | — | 10.00 | PN | Delaware | 2021-09-27 | ↗ |
| 9 | Peter Hudson | 4.08M | 9.60% | — | 4.08M | — | 10.00 | IN | United States of America | 2021-09-27 | ↗ |
| 10 | Canaan Partners XI LLC | 3.94M | 9.50% | 3.94M | — | 3.94M | — | OO | — | 2022-02-08 | ↗ |
| 11 | Canaan XI L.P. | 3.94M | 9.50% | 3.94M | — | 3.94M | — | PN | — | 2022-02-08 | ↗ |
| 12 | Abigail P. Johnson | 3.47M | 8.41% | — | — | 3.47M | — | IN | United States of America | 2022-02-09 | ↗ |
| 13 | FMR LLC | 3.47M | 8.41% | 199.9K | — | 3.47M | — | HC | Delaware | 2022-02-09 | ↗ |
| 14 | 2. | 2.52M | 5.90% | — | — | — | 2.52M | IN | Luxembourg | 2021-09-27 | ↗ |
| 15 | BVF Inc. | 2.47M | 5.90% | — | — | — | 2.47M | CO | Delaware | 2022-03-24 | ↗ |
| 16 | BVF Partners L.P. | 2.47M | 5.90% | — | — | — | 2.47M | IA, PN | Delaware | 2022-03-24 | ↗ |
| 17 | Mark N. Lampert | 2.47M | 5.90% | — | — | — | 2.47M | IN | Delaware | 2022-03-24 | ↗ |
| 18 | BVF GP HOLDINGS LLC | 2.32M | 5.60% | — | — | — | 2.32M | OO | Delaware | 2022-03-24 | ↗ |
| 19 | BVF I GP LLC | 1.35M | 3.20% | — | — | — | 1.35M | OO | Delaware | 2022-03-24 | ↗ |
| 20 | Biotechnology Value Fund, L.P. | 1.35M | 3.20% | — | — | — | 1.35M | PN | Delaware | 2022-03-24 | ↗ |
| 21 | BVF II GP LLC | 971.3K | 2.30% | — | — | — | 971.3K | OO | Delaware | 2022-03-24 | ↗ |
| 22 | Biotechnology Value Fund II, L.P. | 971.3K | 2.30% | — | — | — | 971.3K | PN | Delaware | 2022-03-24 | ↗ |
| 23 | TCG Crossover Management, LLC | 937.5K | 2.20% | 937.5K | — | 937.5K | — | IA | Delaware, United States | 2021-09-29 | ↗ |
| 24 | Canaan 2020+ Co-Investment L.P. — Series 7 | 473.4K | 1.10% | 473.4K | — | 473.4K | — | PN | — | 2022-02-08 | ↗ |
| 25 | Canaan Partners 2020+ Co-Investment LLC | 473.4K | 1.10% | 473.4K | — | 473.4K | — | OO | — | 2022-02-08 | ↗ |
| 26 | Aaron I. Davis | 288.1K | 0.70% | — | 288.1K | — | 288.1K | IN | — | 2022-06-16 | ↗ |
| 27 | MVA Investors, LLC | 288.1K | 0.70% | — | 288.1K | — | 288.1K | OO | — | 2022-06-16 | ↗ |
| 28 | BVF Partners OS Ltd. | 129.3K | 1.00% | — | — | — | 129.3K | CO | Delaware | 2022-03-24 | ↗ |
| 29 | Biotechnology Value Trading Fund OS LP | 129.3K | 1.00% | — | — | — | 129.3K | PN | Delaware | 2022-03-24 | ↗ |
| 30 | Siddarth Subramony | 1.2K | 0.00% | 1.2K | — | 1.2K | — | IN | — | 2022-06-16 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
56
-77 vs prev Q
New positions
19
Closed positions
96
Increased
36
Reduced
9
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | 12.20M +— (+0.0%) | 320.70M +150.0M (+87.9%) | 20.44% -0.041 pp | 3.29% +1.183 pp | USD16.31 +61.2% | 18 qtrs — |
| 2 | NEXTECH INVEST, LTD. | 4.06M +— (+0.0%) | 106.63M +49.9M (+87.9%) | 6.80% -0.014 pp | 10.31% +1.671 pp | USD9.30 +182.7% | 4 qtrs — |
| 3 | ALTA PARTNERS MANAGEMENT COMPANY, L.P. | 3.82M -256.9K (-6.3%) | 100.52M +43.4M (+76.1%) | 6.41% -0.444 pp | 97.03% +1.885 pp | USD13.90 +89.1% | 5 qtrs — |
| 4 | COMMODORE CAPITAL LP | 3.38M +— (+0.0%) | 88.73M +41.5M (+87.9%) | 5.66% -0.011 pp | 5.91% +3.601 pp | USD9.85 +166.9% | 4 qtrs — |
| 5 | CANAAN PARTNERS XI LLC | 3.37M -233.8K (-6.5%) | 88.71M +38.2M (+75.7%) | 5.65% -0.404 pp | 64.85% +15.775 pp | USD14.07 +86.9% | 17 qtrs — |
| 6 | JANUS HENDERSON GROUP PLC | 2.94M +60.6K (+2.1%) | 77.08M +36.9M (+91.6%) | 4.92% +0.092 pp | 0.03% +0.016 pp | USD15.93 +65.0% | 6 qtrs — |
| 7 | TCG CROSSOVER MANAGEMENT, LLC | 2.90M +— (+0.0%) | 76.19M +35.6M (+87.9%) | 4.86% -0.010 pp | 2.52% +0.527 pp | USD10.10 +160.3% | 17 qtrs — |
| 8 | VESTAL POINT CAPITAL, LP | 2.43M +— (+0.0%) | 63.75M +29.8M (+87.9%) | 4.06% -0.008 pp | 2.17% +0.636 pp | USD10.88 +141.6% | 5 qtrs — |
| 9 | BVF INC/IL | 2.13M -1.5M (-41.7%) | 55.94M +4.9M (+9.5%) | 3.57% -2.563 pp | 1.88% -0.187 pp | USD16.22 +62.1% | 18 qtrs — |
| 10 | BLACKROCK, INC. | 2.09M +216.9K (+11.6%) | 54.85M +28.7M (+109.7%) | 3.50% +0.357 pp | 0.00% +0.001 pp | USD21.59 +21.8% | 6 qtrs — |
| 11 | FARALLON CAPITAL MANAGEMENT LLC | 2.07M +923.0K (+80.7%) | 54.34M +38.3M (+239.6%) | 3.46% +1.543 pp | 0.26% +0.191 pp | USD19.12 +37.5% | 5 qtrs — |
| 12 | VANGUARD GROUP INC | 1.57M +52.6K (+3.5%) | 41.35M +20.1M (+94.4%) | 2.64% +0.083 pp | 0.00% +0.000 pp | USD14.54 +80.8% | 17 qtrs — |
| 13 | KYNAM CAPITAL MANAGEMENT, LP | 1.56M -765.5K (-32.9%) | 41.13M +8.5M (+26.2%) | 2.62% -1.291 pp | 2.63% +0.200 pp | USD10.55 +149.2% | 9 qtrs — |
| 14 | 5AM VENTURE MANAGEMENT, LLC | 1.03M +90.0K (+9.6%) | 27.06M +13.9M (+105.9%) | 1.73% +0.148 pp | 8.51% +3.694 pp | USD16.04 +63.9% | 10 qtrs — |
| 15 | CALIGAN PARTNERS LP | 944.3K +247.4K (+35.5%) | 24.82M +15.1M (+154.6%) | 1.58% +0.412 pp | 2.04% +0.767 pp | USD16.32 +61.1% | 4 qtrs — |
| 16 | POINT72 ASSET MANAGEMENT, L.P. | 874.2K +592.2K (+210.0%) | 22.98M +19.0M (+482.5%) | 1.47% +0.991 pp | 0.03% +0.019 pp | USD21.24 +23.8% | 5 qtrs — |
| 17 | BALYASNY ASSET MANAGEMENT L.P. | 818.3K -28.3K (-3.3%) | 21.51M +9.7M (+81.6%) | 1.37% -0.050 pp | 0.03% +0.012 pp | USD10.87 +141.9% | 6 qtrs — |
| 18 | STATE STREET CORP | 749.5K +321.0K (+74.9%) | 19.70M +13.7M (+228.7%) | 1.26% +0.537 pp | 0.00% +0.001 pp | USD19.55 +34.5% | 17 qtrs — |
| 19 | MARSHALL WACE, LLP | 711.9K +109.9K (+18.3%) | 18.72M +10.3M (+122.2%) | 1.19% +0.182 pp | 0.02% +0.009 pp | USD13.70 +91.9% | 9 qtrs — |
| 20 | GEODE CAPITAL MANAGEMENT, LLC | 657.8K +60.3K (+10.1%) | 17.30M +8.9M (+106.9%) | 1.10% +0.099 pp | 0.00% +0.001 pp | USD15.39 +70.8% | 17 qtrs — |
| 21 | SIO CAPITAL MANAGEMENT, LLC | 526.0K +11.1K (+2.1%) | 13.83M +6.6M (+92.0%) | 0.88% +0.017 pp | 2.18% +0.352 pp | USD12.00 +119.1% | 8 qtrs — |
| 22 | BOONE CAPITAL MANAGEMENT LLC | 398.5K +398.5K (+100.0%) | 10.48M +10.5M (+100.0%) | 0.67% +0.668 pp | 3.29% +3.288 pp | USD26.29 +0.0% | 1 qtrs NEW |
| 23 | EVERSEPT PARTNERS, LP | 278.6K +5.9K (+2.1%) | 7.32M +3.5M (+92.0%) | 0.47% +0.009 pp | 0.37% +0.106 pp | USD14.25 +84.5% | 2 qtrs — |
| 24 | BOOTHBAY FUND MANAGEMENT, LLC | 221.2K +34.5K (+18.5%) | 5.81M +3.2M (+122.7%) | 0.37% +0.057 pp | 0.09% +0.049 pp | USD15.91 +65.2% | 2 qtrs — |
| 25 | LOGOS GLOBAL MANAGEMENT LP | 210.0K +210.0K (+100.0%) | 5.52M +5.5M (+100.0%) | 0.35% +0.352 pp | 0.33% +0.334 pp | USD26.29 +0.0% | 1 qtrs NEW |
| 26 | NORTHERN TRUST CORP | 201.0K -7.5K (-3.6%) | 5.28M +2.4M (+81.1%) | 0.34% -0.013 pp | 0.00% +0.000 pp | USD16.84 +56.1% | 17 qtrs — |
| 27 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 199.4K -2.2K (-1.1%) | 5.24M +2.4M (+85.9%) | 0.33% -0.004 pp | 0.00% +0.000 pp | USD14.31 +83.7% | 17 qtrs — |
| 28 | GOLDMAN SACHS GROUP INC | 182.4K +82.2K (+82.1%) | 4.79M +3.4M (+242.2%) | 0.31% +0.138 pp | 0.00% +0.000 pp | USD19.64 +33.9% | 8 qtrs — |
| 29 | RAYMOND JAMES FINANCIAL INC | 170.0K +43.7K (+34.5%) | 4.47M +2.7M (+152.8%) | 0.29% +0.073 pp | 0.00% +0.001 pp | USD16.89 +55.7% | 5 qtrs — |
| 30 | BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 129.8K +129.8K (+100.0%) | 3.41M +3.4M (+100.0%) | 0.22% +0.218 pp | 0.00% +0.004 pp | USD26.29 +0.0% | 1 qtrs NEW |
| 31 | JACOBS LEVY EQUITY MANAGEMENT, INC | 129.8K -121.8K (-48.4%) | 3.41M -108.1K (-3.1%) | 0.22% -0.205 pp | 0.01% -0.001 pp | USD12.21 +115.3% | 5 qtrs — |
| 32 | INVESCO LTD. | 129.4K +113.9K (+734.5%) | 3.40M +3.2M (+1,468.2%) | 0.22% +0.191 pp | 0.00% +0.001 pp | USD24.82 +5.9% | 2 qtrs — |
| 33 | SOLEUS CAPITAL MANAGEMENT, L.P. | 125.0K +125.0K (+100.0%) | 3.29M +3.3M (+100.0%) | 0.21% +0.210 pp | 0.12% +0.121 pp | USD26.29 +0.0% | 1 qtrs NEW |
| 34 | BNP PARIBAS ARBITRAGE, SNC | 120.3K -8.6K (-6.7%) | 3.16M +1.4M (+75.4%) | 0.20% -0.015 pp | 0.00% +0.001 pp | USD10.65 +146.9% | 5 qtrs — |
| 35 | MORGAN STANLEY | 118.9K -203.2K (-63.1%) | 3.13M -1.4M (-30.6%) | 0.20% -0.342 pp | 0.00% 0.000 pp | USD10.61 +147.8% | 17 qtrs — |
| 36 | MILLENNIUM MANAGEMENT LLC | 114.4K -29.6K (-20.6%) | 3.01M +992.5K (+49.3%) | 0.19% -0.050 pp | 0.00% +0.000 pp | USD13.11 +100.5% | 6 qtrs — |
| 37 | TWO SIGMA INVESTMENTS, LP | 107.0K -92.4K (-46.3%) | 2.81M +23.5K (+0.8%) | 0.18% -0.156 pp | 0.00% 0.000 pp | USD13.34 +97.1% | 8 qtrs — |
| 38 | WELLINGTON MANAGEMENT GROUP LLP | 104.3K +21.4K (+25.9%) | 2.74M +1.6M (+136.5%) | 0.17% +0.036 pp | 0.00% +0.000 pp | USD16.73 +57.1% | 18 qtrs — |
| 39 | DIMENSIONAL FUND ADVISORS LP | 95.6K +56.0K (+141.0%) | 2.51M +2.0M (+353.0%) | 0.16% +0.094 pp | 0.00% +0.000 pp | USD21.72 +21.0% | 11 qtrs — |
| 40 | INVESTMENT COUNSEL CO OF NEVADA | 85.0K +— (+0.0%) | 2.24M +1.0M (+87.9%) | 0.14% 0.000 pp | 4.80% +2.380 pp | USD13.90 +89.1% | 5 qtrs — |
| 41 | OPPENHEIMER & CO INC | 84.7K +2.5K (+3.0%) | 2.23M +1.1M (+93.6%) | 0.14% +0.004 pp | 0.03% +0.018 pp | USD17.40 +51.1% | 8 qtrs — |
| 42 | — | 79.6K +79.6K (+100.0%) | 2.09M +2.1M (+100.0%) | 0.13% +0.133 pp | 1.59% +1.591 pp | USD26.29 +0.0% | 1 qtrs NEW |
| 43 | BARCLAYS PLC | 76.3K +38.7K (+102.8%) | 2.01M +1.1M (+126.8%) | 0.13% +0.065 pp | 0.00% +0.000 pp | USD21.48 +22.4% | 16 qtrs — |
| 44 | JPMORGAN CHASE & CO | 71.2K -3.1K (-4.1%) | 1.87M +832.7K (+80.2%) | 0.12% -0.005 pp | 0.00% +0.000 pp | USD14.30 +83.8% | 17 qtrs — |
| 45 | BANK OF NEW YORK MELLON CORP | 60.9K +3.7K (+6.5%) | 1.60M +801.4K (+100.2%) | 0.10% +0.006 pp | 0.00% +0.000 pp | USD13.17 +99.6% | 17 qtrs — |
| 46 | TWO SIGMA ADVISERS, LP | 58.9K -54.3K (-48.0%) | 1.55M -35.2K (-2.2%) | 0.10% -0.091 pp | 0.00% 0.000 pp | USD10.97 +139.7% | 5 qtrs — |
| 47 | UBS GROUP AG | 58.9K -288.0 (-0.5%) | 1.55M +719.9K (+87.0%) | 0.10% -0.001 pp | 0.00% +0.000 pp | USD14.64 +79.6% | 17 qtrs — |
| 48 | SUPERSTRING CAPITAL MANAGEMENT LP | 58.7K +58.7K (+100.0%) | 1.54M +1.5M (+100.0%) | 0.10% +0.098 pp | 0.83% +0.826 pp | USD26.29 +0.0% | 1 qtrs NEW |
| 49 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 55.1K +55.1K (+100.0%) | 1.45M +1.4M (+100.0%) | 0.09% +0.092 pp | 0.00% +0.000 pp | USD26.29 +0.0% | 4 qtrs — |
| 50 | AMERIPRISE FINANCIAL INC | 54.6K -32.5K (-37.3%) | 1.44M +217.5K (+17.8%) | 0.09% -0.055 pp | 0.00% +0.000 pp | USD9.90 +165.6% | 3 qtrs — |
| 51 | SQUAREPOINT OPS LLC | 54.4K +42.2K (+345.6%) | 1.43M +1.3M (+737.3%) | 0.09% +0.071 pp | 0.00% +0.001 pp | USD22.54 +16.6% | 5 qtrs — |
| 52 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 48.6K +— (+0.0%) | 1.28M +598.3K (+87.9%) | 0.08% 0.000 pp | 0.02% +0.009 pp | USD9.57 +174.7% | 3 qtrs — |
| 53 | NUVEEN, LLC | 47.3K -33.1K (-41.1%) | 1.24M +119.4K (+10.6%) | 0.08% -0.056 pp | 0.00% +0.000 pp | USD9.40 +179.7% | 4 qtrs — |
| 54 | ALGERT GLOBAL LLC | 46.9K +46.9K (+100.0%) | 1.23M +1.2M (+100.0%) | 0.08% +0.079 pp | 0.02% +0.019 pp | USD26.29 +0.0% | 1 qtrs NEW |
| 55 | AMERICAN CENTURY COMPANIES INC | 46.2K +7.8K (+20.3%) | 1.22M +677.9K (+126.2%) | 0.08% +0.013 pp | 0.00% +0.000 pp | USD16.88 +55.7% | 9 qtrs — |
| 56 | Y-INTERCEPT (HONG KONG) LTD | 45.9K +45.9K (+100.0%) | 1.21M +1.2M (+100.0%) | 0.08% +0.077 pp | 0.03% +0.027 pp | USD26.29 +0.0% | 1 qtrs NEW |
| 57 | ALPS ADVISORS INC | 43.8K +19.1K (+77.4%) | 1.15M +806.7K (+233.4%) | 0.07% +0.032 pp | 0.01% +0.005 pp | USD16.87 +55.8% | 3 qtrs — |
| 58 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 42.8K +42.8K (+100.0%) | 1.12M +1.1M (+100.0%) | 0.07% +0.072 pp | 0.01% +0.009 pp | USD26.29 +0.0% | 4 qtrs — |
| 59 | PDT PARTNERS, LLC | 42.3K -1.0K (-2.4%) | 1.11M +505.7K (+83.5%) | 0.07% -0.002 pp | 0.07% +0.034 pp | USD9.57 +174.7% | 8 qtrs — |
| 60 | STATE OF WISCONSIN INVESTMENT BOARD | 39.0K +9.4K (+31.6%) | 1.03M +611.1K (+147.3%) | 0.07% +0.016 pp | 0.00% +0.001 pp | USD17.19 +52.9% | 7 qtrs — |
| 61 | RHUMBLINE ADVISERS | 38.8K -1.8K (-4.5%) | 1.02M +451.3K (+79.4%) | 0.07% -0.003 pp | 0.00% +0.000 pp | USD10.83 +142.8% | 16 qtrs — |
| 62 | BANK OF AMERICA CORP /DE/ | 38.3K -96.0K (-71.5%) | 1.01M -872.0K (-46.4%) | 0.06% -0.161 pp | 0.00% 0.000 pp | USD10.51 +150.1% | 18 qtrs — |
| 63 | HIGHVISTA STRATEGIES LLC | 35.1K -30.7K (-46.7%) | 922.4K +1.7K (+0.2%) | 0.06% -0.052 pp | 0.24% +0.012 pp | USD14.71 +78.7% | 7 qtrs — |
| 64 | ALLIANCEBERNSTEIN L.P. | 32.0K -1.3K (-3.8%) | 841.0K +375.7K (+80.7%) | 0.05% -0.002 pp | 0.00% +0.000 pp | USD13.37 +96.6% | 7 qtrs — |
| 65 | XTX TOPCO LTD | 30.4K -3.3K (-9.8%) | 799.6K +328.1K (+69.6%) | 0.05% -0.006 pp | 0.02% -0.004 pp | USD9.57 +174.7% | 3 qtrs — |
| 66 | VOYA INVESTMENT MANAGEMENT LLC | 29.9K +29.9K (+100.0%) | 785.7K +785.7K (+100.0%) | 0.05% +0.050 pp | 0.00% +0.001 pp | USD26.29 +0.0% | 1 qtrs NEW |
| 67 | WELLS FARGO & COMPANY/MN | 29.0K +10.6K (+57.3%) | 763.7K +505.3K (+195.6%) | 0.05% +0.018 pp | 0.00% +0.000 pp | USD18.06 +45.6% | 12 qtrs — |
| 68 | CANADA PENSION PLAN INVESTMENT BOARD | 28.9K +28.9K (+100.0%) | 759.8K +759.8K (+100.0%) | 0.05% +0.048 pp | 0.00% +0.001 pp | USD26.29 +0.0% | 1 qtrs NEW |
| 69 | FISHER ASSET MANAGEMENT, LLC | 28.8K +28.8K (+100.0%) | 757.2K +757.2K (+100.0%) | 0.05% +0.048 pp | 0.00% +0.000 pp | USD26.29 +0.0% | 1 qtrs NEW |
| 70 | AQR CAPITAL MANAGEMENT LLC | 28.6K +562.0 (+2.0%) | 752.7K +360.0K (+91.7%) | 0.05% +0.001 pp | 0.00% +0.000 pp | USD9.90 +165.6% | 3 qtrs — |
| 71 | AUOUR INVESTMENTS LLC | 21.0K +— (+0.0%) | 552.6K +258.5K (+87.9%) | 0.04% 0.000 pp | 0.18% +0.080 pp | USD17.03 +54.4% | 11 qtrs — |
| 72 | CREATIVE PLANNING | 19.6K +19.6K (+100.0%) | 515.4K +515.4K (+100.0%) | 0.03% +0.033 pp | 0.00% +0.000 pp | USD26.29 +0.0% | 1 qtrs NEW |
| 73 | VICTORY CAPITAL MANAGEMENT INC | 18.8K +— (+0.0%) | 494.0K +231.1K (+87.9%) | 0.03% 0.000 pp | 0.00% +0.000 pp | USD14.64 +79.6% | 12 qtrs — |
| 74 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 18.5K -6.4K (-25.7%) | 487.5K +138.3K (+39.6%) | 0.03% -0.011 pp | 0.00% +0.000 pp | USD10.71 +145.5% | 3 qtrs — |
| 75 | DEUTSCHE BANK AG\ | 16.4K +894.0 (+5.8%) | 430.6K +213.9K (+98.8%) | 0.03% +0.001 pp | 0.00% +0.000 pp | USD16.58 +58.6% | 17 qtrs — |
| 76 | RAFFERTY ASSET MANAGEMENT, LLC | 15.5K +15.5K (+100.0%) | 406.3K +406.3K (+100.0%) | 0.03% +0.026 pp | 0.00% +0.001 pp | USD26.29 +0.0% | 1 qtrs NEW |
| 77 | METLIFE INVESTMENT MANAGEMENT, LLC | 15.4K +725.0 (+5.0%) | 403.7K +199.0K (+97.2%) | 0.03% +0.001 pp | 0.00% +0.001 pp | USD15.88 +65.6% | 12 qtrs — |
| 78 | PRICE T ROWE ASSOCIATES INC /MD/ | 14.4K +1.6K (+12.7%) | 380.0K +200.0K (+111.1%) | 0.02% +0.003 pp | 0.00% +0.000 pp | USD11.70 +124.7% | 3 qtrs — |
| 79 | RUSSELL INVESTMENTS GROUP, LTD. | 13.0K +255.0 (+2.0%) | 341.7K +163.4K (+91.7%) | 0.02% +0.000 pp | 0.00% +0.000 pp | USD14.16 +85.7% | 11 qtrs — |
| 80 | FRANKLIN RESOURCES INC | 13.0K +13.0K (+100.0%) | 341.0K +341.0K (+100.0%) | 0.02% +0.022 pp | 0.00% +0.000 pp | USD26.29 +0.0% | 1 qtrs NEW |
| 81 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 12.9K +1.6K (+14.1%) | 338.6K +180.3K (+113.9%) | 0.02% +0.003 pp | 0.00% +0.000 pp | USD19.30 +36.2% | 7 qtrs — |
| 82 | FMR LLC | 12.6K +34.0 (+0.3%) | 330.3K +155.0K (+88.4%) | 0.02% +0.000 pp | 0.00% +0.000 pp | USD15.99 +64.4% | 18 qtrs — |
| 83 | CITADEL ADVISORS LLC | 12.5K -11.0K (-46.8%) | 328.6K -140.0 (0.0%) | 0.02% -0.019 pp | 0.00% +0.000 pp | USD13.99 +87.9% | 8 qtrs — |
| 84 | VIRTUS INVESTMENT ADVISERS, INC. | 11.8K +741.0 (+6.7%) | 309.1K +155.0K (+100.6%) | 0.02% +0.001 pp | 0.08% +0.040 pp | USD11.13 +136.2% | 4 qtrs — |
| 85 | BANK OF NOVA SCOTIA | 11.1K +11.1K (+100.0%) | 291.8K +291.8K (+100.0%) | 0.02% +0.019 pp | 0.00% +0.000 pp | USD26.29 +0.0% | 1 qtrs NEW |
| 86 | BAKER BROS. ADVISORS LP | 10.6K +— (+0.0%) | 278.9K +130.5K (+87.9%) | 0.02% +0.000 pp | 0.00% +0.001 pp | USD13.85 +89.8% | 9 qtrs — |
| 87 | INTECH INVESTMENT MANAGEMENT LLC | 9.8K -1.6K (-14.0%) | 257.7K +98.2K (+61.5%) | 0.02% -0.003 pp | 0.00% +0.001 pp | USD9.39 +180.0% | 4 qtrs — |
| 88 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 8.7K -645.0 (-6.9%) | 228.6K +97.9K (+74.9%) | 0.01% -0.001 pp | 0.02% +0.007 pp | USD13.68 +92.2% | 5 qtrs — |
| 89 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 8.4K +8.4K (+100.0%) | 219.7K +219.7K (+100.0%) | 0.01% +0.014 pp | 0.00% +0.000 pp | USD26.29 +0.0% | 1 qtrs NEW |
| 90 | NEW YORK STATE COMMON RETIREMENT FUND | 7.4K +— (+0.0%) | 195.2K +91.3K (+87.9%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD16.11 +63.2% | 16 qtrs — |
| 91 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 6.4K +— (+0.0%) | 169.3K +79.2K (+87.9%) | 0.01% +0.000 pp | 0.00% +0.001 pp | USD13.92 +88.9% | 5 qtrs — |
| 92 | CITIGROUP INC | 3.8K +2.1K (+123.6%) | 100.3K +76.5K (+320.2%) | 0.01% +0.004 pp | 0.00% +0.000 pp | USD23.62 +11.3% | 18 qtrs — |
| 93 | BELLEVUE GROUP AG | 3.1K +3.1K (+100.0%) | 82.6K +82.6K (+100.0%) | 0.01% +0.005 pp | 0.00% +0.002 pp | USD26.29 +0.0% | 1 qtrs NEW |
| 94 | CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 3.0K +3.0K (+100.0%) | 78.8K +78.8K (+100.0%) | 0.01% +0.005 pp | 0.02% +0.019 pp | USD26.29 +0.0% | 4 qtrs — |
| 95 | MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 2.6K +534.0 (+25.9%) | 68.2K +39.4K (+136.6%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD15.83 +66.1% | 5 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 94 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Tema Oncology ETF CANC | 1.04% | 1.48M | 0.75% |
| 2 | ALPS Medical Breakthroughs ETF SBIO | 1.00% | 2.12M | 0.50% |
| 3 | Virtus Biotech Clinical Trials ETF BBC | 0.75% | 429.9K | 0.65% |
| 4 | Global X - S&P Biotech ETF CURE.AX | 0.42% | 152.2K | 0.45% |
| 5 | State Street SPDR S&P Biotech ETF XBI | 0.42% | 45.72M | 0.35% |
| 6 | VictoryShares US Small Mid Cap Value Momentum ETF USVM | 0.20% | 3.44M | 0.29% |
| 7 | Vanguard U.S. Momentum Factor ETF VFMO | 0.16% | 2.78M | 0.13% |
| 8 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.13% | 619.8K | 0.40% |
| 9 | Invesco Nasdaq Biotechnology ETF IBBQ | 0.13% | 100.0K | 0.19% |
| 10 | iShares Nasdaq US Biotechnology UCITS ETF BTEE.L | 0.13% | 98.1K | 0.35% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
11
Sells
0
Shares acquired
687.0K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+687,041
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-05 | Warner Douglas J | Officer | A-Award | A | Stock Option (Right to Buy) | 85,000 | 33.93 | 2.88M | 85,000 | D | ↗ |
| 2026-05-05 | Rueb Yuliya | Officer | A-Award | A | Common Stock | 8,333 | 0.00 | — | 43,354 | D | ↗ |
| 2026-05-05 | Harris Todd | Director / Officer | A-Award | A | Common Stock | 79,000 | 0.00 | — | 1,437,631 | D | ↗ |
| 2026-05-05 | Fuhrman Alan | Officer | A-Award | A | Stock Option (Right to Buy) | 67,000 | 33.93 | 2.27M | 67,000 | D | ↗ |
| 2026-05-05 | Ashar Bhavesh | Officer | A-Award | A | Stock Option (Right to Buy) | 50,295 | 33.93 | 1.71M | 50,295 | D | ↗ |
| 2026-04-16 | Dable Habib J | Director | — | — | No securities are beneficially owned. | 0 | 0.00 | — | 0 | D | ↗ |
| 2026-04-01 | Rueb Yuliya | Officer | — | — | Stock Option (Right to Buy) | 9,034 | 6.50 | 58.7K | 0 | D | ↗ |
| 2026-03-26 | KAPLAN GILLA | Director | M-Exempt | D | Common Stock | 53,172 | 2.25 | 119.6K | 81,403 | D | ↗ |
| 2026-03-25 | KAPLAN GILLA | Director | M-Exempt | D | Stock Option (Right to Buy) | 14,295 | 2.25 | 32.2K | 53,172 | D | ↗ |
| 2026-03-13 | Harris Todd | Director / Officer | A-Award | A | Common Stock | 1,463 | 9.13 | 13.4K | 1,358,631 | D | ↗ |
| 2026-03-13 | Fuhrman Alan | Officer | A-Award | A | Common Stock | 1,376 | 9.13 | 12.6K | 16,164 | D | ↗ |
| 2026-02-12 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 2,128 | 31.50 | 67.0K | 152,853 | D | ↗ |
| 2026-01-12 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 6,983 | 28.44 | 198.6K | 155,998 | D | ↗ |
| 2025-12-19 | MORE ROBERT J | Director | S-Sale | D | Common Stock | 10,000 | 25.00 | 250.0K | 3,823,425 | I | ↗ |
| 2025-12-12 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 8,000 | 22.64 | 181.2K | 162,981 | D | ↗ |
| 2025-12-01 | Ashar Bhavesh | Officer | A-Award | A | Stock Option (Right to Buy) | 300,000 | 20.81 | 6.24M | 300,000 | D | ↗ |
| 2025-11-21 | MORE ROBERT J | Director | S-Sale | D | Common Stock | 246,871 | 20.25 | 5.00M | 3,833,425 | I | ↗ |
| 2025-11-19 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 49,956 | 16.32 | 815.3K | 170,981 | D | ↗ |
| 2025-11-18 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 75,633 | 16.07 | 1.22M | 220,937 | D | ↗ |
| 2025-11-17 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 18,572 | 16.11 | 299.2K | 298,070 | D | ↗ |
| 2025-11-14 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 110,228 | 16.02 | 1.77M | 316,642 | D | ↗ |
| 2025-11-13 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 1,111 | 16.00 | 17.8K | 426,870 | D | ↗ |
| 2025-09-15 | Fuhrman Alan | Officer | A-Award | A | Common Stock | 701 | 9.13 | 6.4K | 14,788 | D | ↗ |
| 2025-08-07 | Warner Douglas J | Officer | A-Award | A | Stock Option (Right to Buy) | 200,000 | 10.75 | 2.15M | 200,000 | D | ↗ |
| 2025-08-07 | Harris Todd | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 570,000 | 10.75 | 6.13M | 570,000 | D | ↗ |
| 2025-08-07 | Fuhrman Alan | Officer | A-Award | A | Stock Option (Right to Buy) | 170,000 | 10.75 | 1.83M | 170,000 | D | ↗ |
| 2025-08-07 | Bensen Daniel | Officer | A-Award | A | Stock Option (Right to Buy) | 170,000 | 10.75 | 1.83M | 170,000 | D | ↗ |
| 2025-06-18 | KAPLAN GILLA | Director | S-Sale | D | Common Stock | 9,568 | 9.78 | 93.6K | 28,231 | D | ↗ |
| 2025-06-17 | KAPLAN GILLA | Director | S-Sale | D | Common Stock | 10 | 10.35 | 103.50 | 37,799 | D | ↗ |
| 2025-06-16 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | P-Purchase | A | Common Stock | 11,813 | 10.13 | 119.7K | 10,259,291 | I | ↗ |
| 2025-06-16 | KAPLAN GILLA | Director | S-Sale | D | Common Stock | 6,814 | 10.38 | 70.7K | 37,809 | D | ↗ |
| 2025-06-13 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | P-Purchase | A | Common Stock | 120,167 | 10.20 | 1.23M | 10,247,478 | I | ↗ |
| 2025-06-13 | KAPLAN GILLA | Director | S-Sale | D | Common Stock | 15,000 | 10.31 | 154.6K | 44,623 | D | ↗ |
| 2025-06-12 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | P-Purchase | A | Common Stock | 31,307 | 10.20 | 319.3K | 10,127,311 | I | ↗ |
| 2025-06-12 | KAPLAN GILLA | Director | S-Sale | D | Common Stock | 30,000 | 10.31 | 309.3K | 59,623 | D | ↗ |
| 2025-06-09 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | P-Purchase | A | Common Stock | 186,850 | 10.19 | 1.90M | 10,096,004 | I | ↗ |
| 2025-06-05 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | P-Purchase | A | Common Stock | 213,334 | 10.04 | 2.14M | 9,909,154 | I | ↗ |
| 2025-06-04 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | P-Purchase | A | Common Stock | 997,864 | 9.63 | 9.61M | 9,695,820 | I | ↗ |
| 2025-05-29 | Verjee Rehan | Director | A-Award | A | Stock Option (Right to Buy) | 22,200 | 9.25 | 205.4K | 22,200 | D | ↗ |
| 2025-05-29 | Simson Jake | Director | A-Award | A | Stock Option (Right to Buy) | 22,200 | 9.25 | 205.4K | 22,200 | D | ↗ |
| 2025-05-29 | Rothenberg Stephen Michael | Director | A-Award | A | Stock Option (Right to Buy) | 22,200 | 9.25 | 205.4K | 22,200 | D | ↗ |
| 2025-05-29 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 22,200 | 9.25 | 205.4K | 22,200 | I | ↗ |
| 2025-05-29 | Moran Susan | Director | A-Award | A | Stock Option (Right to Buy) | 22,200 | 9.25 | 205.4K | 22,200 | D | ↗ |
| 2025-05-29 | MORE ROBERT J | Director | A-Award | A | Stock Option (Right to Buy) | 22,200 | 9.25 | 205.4K | 22,200 | D | ↗ |
| 2025-05-29 | KAPLAN GILLA | Director | A-Award | A | Stock Option (Right to Buy) | 22,200 | 9.25 | 205.4K | 22,200 | D | ↗ |
| 2025-03-14 | Harris Todd | Director / Officer | A-Award | A | Common Stock | 1,241 | 9.78 | 12.1K | 1,357,168 | D | ↗ |
| 2025-03-14 | Fuhrman Alan | Officer | A-Award | A | Common Stock | 1,238 | 9.78 | 12.1K | 14,087 | D | ↗ |
| 2025-02-05 | Kjellson Nina S | Director | S-Sale | D | Common Stock | 1,890 | 13.76 | 26.0K | 3,700,705 | I | ↗ |
| 2025-01-29 | Gulfo Adele M. | Director | A-Award | A | Common Stock (Right to Buy) | 37,200 | 14.65 | 545.0K | 37,200 | D | ↗ |
| 2025-01-23 | Kjellson Nina S | Director | S-Sale | D | Common Stock | 4,825 | 16.26 | 78.5K | 3,702,595 | I | ↗ |
| 2025-01-21 | Kjellson Nina S | Director | S-Sale | D | Common Stock | 3,993 | 16.36 | 65.3K | 3,707,420 | I | ↗ |
| 2025-01-17 | Kjellson Nina S | Director | S-Sale | D | Common Stock | 12,808 | 16.40 | 210.1K | 3,711,413 | I | ↗ |
| 2025-01-16 | Kjellson Nina S | Director | S-Sale | D | Common Stock | 6,944 | 16.29 | 113.1K | 3,724,221 | I | ↗ |
| 2024-11-25 | Kjellson Nina S | Director | S-Sale | D | Common Stock | 4,706 | 16.84 | 79.2K | 3,731,165 | I | ↗ |
| 2024-11-08 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | P-Purchase | A | Common Stock | 1,220,681 | 16.25 | 19.84M | 8,697,956 | I | ↗ |
| 2024-11-07 | Kjellson Nina S | Director | S-Sale | D | Common Stock | 19,720 | 17.32 | 341.5K | 3,735,871 | I | ↗ |
| 2024-11-06 | Kjellson Nina S | Director | S-Sale | D | Common Stock | 46,856 | 17.18 | 804.8K | 3,755,591 | I | ↗ |
| 2024-11-05 | Kjellson Nina S | Director | S-Sale | D | Common Stock | 9,367 | 16.77 | 157.1K | 3,802,447 | I | ↗ |
| 2024-11-04 | Kjellson Nina S | Director | S-Sale | D | Common Stock | 960 | 17.01 | 16.3K | 3,811,814 | I | ↗ |
| 2024-11-01 | Kjellson Nina S | Director | S-Sale | D | Commmon Stock | 604 | 17.16 | 10.4K | 3,812,774 | I | ↗ |
| 2024-10-31 | Kjellson Nina S | Director | S-Sale | D | Common Stock | 89,390 | 16.46 | 1.47M | 3,837,316 | I | ↗ |
| 2024-10-30 | Kjellson Nina S | Director | S-Sale | D | Common Stock | 1,189 | 16.17 | 19.2K | 472,207 | I | ↗ |
| 2024-10-30 | Fuhrman Alan | Officer | P-Purchase | A | Common Stock | 9,500 | 16.00 | 152.0K | 12,849 | D | ↗ |
| 2024-10-21 | Harris Todd | Director / Officer | S-Sale | D | Common Stock | 5,896 | 27.32 | 161.1K | 1,369,115 | D | ↗ |
| 2024-10-18 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | J-Other | A | Pre-Funded Warrants (Right to Buy) | 2,358,457 | 0.00 | 2.4K | 1,000,000 | I | ↗ |
| 2024-10-18 | Harris Todd | Director / Officer | S-Sale | D | Common Stock | 43,636 | 27.01 | 1.18M | 1,375,011 | D | ↗ |
| 2024-10-18 | Boxer Capital Management, LLC | Other | D-Return | D | Common Stock | 2,000,000 | 0.00 | — | 4,448,359 | I | ↗ |
| 2024-10-17 | Harris Todd | Director / Officer | S-Sale | D | Common Stock | 200 | 26.37 | 5.3K | 1,418,647 | D | ↗ |
| 2024-10-16 | Harris Todd | Director / Officer | S-Sale | D | Common Stock | 4,900 | 25.22 | 123.6K | 1,462,438 | D | ↗ |
| 2024-10-15 | Harris Todd | Director / Officer | S-Sale | D | Common Stock | 10,035 | 24.31 | 244.0K | 1,467,338 | D | ↗ |
| 2024-10-10 | Boxer Capital Management, LLC | Other | — | — | Warrant (right to purchase) | 705,280 | 13.01 | 9.17M | 0 | I | ↗ |
| 2024-09-30 | Harris Todd | Director / Officer | S-Sale | D | Common Stock | 500 | 24.00 | 12.0K | 1,477,373 | D | ↗ |
| 2024-09-25 | Harris Todd | Director / Officer | S-Sale | D | Common Stock | 600 | 24.01 | 14.4K | 1,477,873 | D | ↗ |
| 2024-09-24 | Harris Todd | Director / Officer | S-Sale | D | Common Stock | 1,055 | 24.02 | 25.3K | 1,478,473 | D | ↗ |
| 2024-09-23 | Harris Todd | Director / Officer | S-Sale | D | Common Stock | 10,092 | 24.13 | 243.5K | 1,479,528 | D | ↗ |
| 2024-09-20 | Harris Todd | Director / Officer | S-Sale | D | Common Stock | 7,109 | 24.19 | 172.0K | 1,489,620 | D | ↗ |
| 2024-09-19 | Harris Todd | Director / Officer | S-Sale | D | Common Stock | 5,671 | 24.30 | 137.8K | 1,496,756 | D | ↗ |
| 2024-09-18 | Harris Todd | Director / Officer | S-Sale | D | Common Stock | 3,500 | 24.00 | 84.0K | 1,502,427 | D | ↗ |
| 2024-09-13 | Harris Todd | Director / Officer | A-Award | A | Common Stock | 1,350 | 6.58 | 8.9K | 1,505,927 | — | ↗ |
| 2024-09-13 | Fuhrman Alan | Officer | A-Award | A | Common Stock | 954 | 12.48 | 11.9K | 3,349 | — | ↗ |
| 2024-09-09 | Warner Douglas J | Officer | A-Award | A | Stock Option (Right to Buy) | 260,000 | 21.51 | 5.59M | 260,000 | — | ↗ |
| 2024-08-14 | Harris Todd | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 390,000 | 21.57 | 8.41M | 390,000 | — | ↗ |
| 2024-08-14 | Fuhrman Alan | Officer | A-Award | A | Stock Option (Right to Buy) | 115,000 | 21.57 | 2.48M | 115,000 | — | ↗ |
| 2024-08-14 | Bensen Daniel | Officer | A-Award | A | Stock Option (Right to Buy) | 115,000 | 21.57 | 2.48M | 115,000 | — | ↗ |
| 2024-06-13 | KAPLAN GILLA | Director | M-Exempt | A | Common Stock | 61,392 | 0.61 | 37.4K | 89,623 | — | ↗ |
| 2024-06-10 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 3,502 | 20.00 | 70.0K | 427,981 | — | ↗ |
| 2024-06-07 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 200 | 20.00 | 4.0K | 431,483 | — | ↗ |
| 2024-05-29 | Verjee Rehan | Director | A-Award | A | Stock Option (Right to Buy) | 18,600 | 15.94 | 296.5K | 18,600 | — | ↗ |
| 2024-05-29 | Subramony Siddarth | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 18,600 | 15.94 | 296.5K | 18,600 | — | ↗ |
| 2024-05-29 | Simson Jake | Director | A-Award | A | Stock Option (Right to Buy) | 18,600 | 15.94 | 296.5K | 18,600 | — | ↗ |
| 2024-05-29 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | A-Award | A | Stock Option (right to buy) | 18,600 | 15.94 | 296.5K | 18,600 | — | ↗ |
| 2024-05-29 | MORE ROBERT J | Director | A-Award | A | Stock Option (Right to Buy) | 18,600 | 15.94 | 296.5K | 18,600 | — | ↗ |
| 2024-05-29 | Kjellson Nina S | Director | A-Award | A | Stock Option (Right to Buy) | 18,600 | 15.94 | 296.5K | 18,600 | — | ↗ |
| 2024-05-29 | KAPLAN GILLA | Director | A-Award | A | Stock Option (Right to Buy) | 18,600 | 15.94 | 296.5K | 18,600 | — | ↗ |
| 2024-05-07 | Rothenberg Stephen Michael | Director | A-Award | A | Common Stock (Right to Buy) | 37,200 | 17.94 | 667.4K | 37,200 | — | ↗ |
| 2024-05-07 | Moran Susan | Director | A-Award | A | Common Stock (Right to Buy) | 37,200 | 17.94 | 667.4K | 37,200 | — | ↗ |
| 2024-03-15 | Tada Hiroomi | Officer | A-Award | A | Common Stock | 1,968 | 6.58 | 12.9K | 86,435 | — | ↗ |
| 2024-03-15 | Harris Todd | Director / Officer | A-Award | A | Common Stock | 1,880 | 6.58 | 12.4K | 1,504,577 | — | ↗ |
| 2024-03-15 | Fuhrman Alan | Officer | A-Award | A | Common Stock | 932 | 12.48 | 11.6K | 2,395 | — | ↗ |
| 2024-03-11 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 200 | 20.00 | 4.0K | 431,683 | — | ↗ |
| 2024-03-07 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 68 | 20.00 | 1.4K | 431,883 | — | ↗ |
| 2024-03-06 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 1,733 | 20.09 | 34.8K | 431,951 | — | ↗ |
| 2024-03-05 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 1,189 | 20.02 | 23.8K | 433,684 | — | ↗ |
| 2024-03-04 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 5,063 | 20.08 | 101.7K | 434,873 | — | ↗ |
| 2024-03-01 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 2,900 | 20.04 | 58.1K | 439,936 | — | ↗ |
| 2024-02-29 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 2,050 | 20.00 | 41.0K | 442,836 | — | ↗ |
| 2024-02-28 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 5,849 | 20.13 | 117.7K | 444,886 | — | ↗ |
| 2024-02-27 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 745 | 20.00 | 14.9K | 450,735 | — | ↗ |
| 2024-02-12 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 1,501 | 20.00 | 30.0K | 451,480 | — | ↗ |
| 2024-02-07 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 9,587 | 18.09 | 173.5K | 452,981 | — | ↗ |
| 2024-02-06 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | A-Award | A | Common Stock | 3,180,155 | 13.01 | 41.37M | 8,477,275 | — | ↗ |
| 2024-02-06 | Boxer Capital, LLC | Other | A-Award | A | Warrant (right to purchase) | 705,280 | 0.00 | 705.28 | 705,280 | — | ↗ |
| 2024-02-06 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 15,413 | 18.09 | 278.8K | 462,568 | — | ↗ |
| 2024-02-05 | Harris Todd | Director / Officer | S-Sale | D | Common Stock | 13,817 | 16.97 | 234.4K | 1,502,697 | — | ↗ |
| 2024-02-02 | Harris Todd | Director / Officer | S-Sale | D | Common Stock | 7,187 | 17.04 | 122.5K | 1,516,514 | — | ↗ |
| 2024-02-02 | Bensen Daniel | Officer | M-Exempt | D | Stock Option (Right to Buy) | 25,393 | 0.61 | 15.5K | 108,110 | — | ↗ |
| 2023-09-15 | Tada Hiroomi | Officer | A-Award | A | Common Stock | 1,337 | 6.58 | 8.8K | 84,467 | — | ↗ |
| 2023-09-15 | Harris Todd | Director / Officer | A-Award | A | Common Stock | 1,421 | 6.58 | 9.3K | 1,602,697 | — | ↗ |
| 2023-09-15 | Fuhrman Alan | Officer | A-Award | A | Common Stock | 1,463 | 12.50 | 18.3K | 1,463 | — | ↗ |
| 2023-07-28 | Tada Hiroomi | Officer | A-Award | A | Stock Option (Right to Buy) | 115,000 | 14.35 | 1.65M | 115,000 | — | ↗ |
| 2023-07-28 | Harris Todd | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 330,000 | 14.35 | 4.74M | 330,000 | — | ↗ |
| 2023-07-28 | Fuhrman Alan | Officer | A-Award | A | Stock Option (Right to Buy) | 62,685 | 14.35 | 899.5K | 62,685 | — | ↗ |
| 2023-07-28 | Bensen Daniel | Officer | A-Award | A | Stock Option (Right to Buy) | 110,000 | 14.35 | 1.58M | 110,000 | — | ↗ |
| 2023-07-21 | Bensen Daniel | Officer | M-Exempt | A | Common Stock | 3,900 | 0.61 | 2.4K | 531,881 | — | ↗ |
| 2023-07-19 | Bensen Daniel | Officer | M-Exempt | D | Stock Option (Right to Buy) | 207 | 0.61 | 126.27 | 137,403 | — | ↗ |
| 2023-07-17 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 1,900 | 16.03 | 30.5K | 527,981 | — | ↗ |
| 2023-07-13 | Bensen Daniel | Officer | M-Exempt | A | Common Stock | 500 | 0.61 | 305.00 | 528,481 | — | ↗ |
| 2023-07-12 | Bensen Daniel | Officer | M-Exempt | A | Common Stock | 201 | 0.61 | 122.61 | 528,182 | — | ↗ |
| 2023-07-11 | Bensen Daniel | Officer | M-Exempt | D | Stock Option (Right to Buy) | 201 | 0.61 | 122.61 | 140,010 | — | ↗ |
| 2023-07-10 | Bensen Daniel | Officer | M-Exempt | D | Stock Option (Right to Buy) | 1,202 | 0.61 | 733.22 | 140,711 | — | ↗ |
| 2023-07-03 | Bensen Daniel | Officer | M-Exempt | A | Common Stock | 4,265 | 0.61 | 2.6K | 532,246 | — | ↗ |
| 2023-06-30 | Bensen Daniel | Officer | M-Exempt | A | Common Stock | 18,819 | 0.61 | 11.5K | 546,800 | — | ↗ |
| 2023-06-29 | Bensen Daniel | Officer | M-Exempt | A | Common Stock | 17,281 | 0.61 | 10.5K | 545,262 | — | ↗ |
| 2023-06-28 | Bensen Daniel | Officer | M-Exempt | A | Common Stock | 13,524 | 0.61 | 8.2K | 541,505 | — | ↗ |
| 2023-06-27 | Bensen Daniel | Officer | M-Exempt | A | Common Stock | 16,028 | 0.61 | 9.8K | 544,009 | — | ↗ |
| 2023-06-26 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 10,862 | 16.49 | 179.1K | 534,351 | — | ↗ |
| 2023-06-23 | Harris Todd | Director / Officer | S-Sale | D | Common Stock | 6,481 | 17.51 | 113.5K | 1,601,276 | — | ↗ |
| 2023-06-22 | Harris Todd | Director / Officer | S-Sale | D | Common Stock | 500 | 17.39 | 8.7K | 1,621,988 | — | ↗ |
| 2023-06-21 | Harris Todd | Director / Officer | S-Sale | D | Common Stock | 4,629 | 16.12 | 74.6K | 1,640,593 | — | ↗ |
| 2023-06-20 | Harris Todd | Director / Officer | S-Sale | D | Common Stock | 1,300 | 16.53 | 21.5K | 1,645,222 | — | ↗ |
| 2023-06-16 | Harris Todd | Director / Officer | S-Sale | D | Common Stock | 3,316 | 16.49 | 54.7K | 1,697,960 | — | ↗ |
| 2023-06-15 | Harris Todd | Director / Officer | S-Sale | D | Common Stock | 12,773 | 16.13 | 206.0K | 1,701,276 | — | ↗ |
| 2023-06-15 | Bensen Daniel | Officer | M-Exempt | A | Common Stock | 12,592 | 0.61 | 7.7K | 540,573 | — | ↗ |
| 2023-06-14 | Bensen Daniel | Officer | M-Exempt | D | Stock Option (Right to Buy) | 120 | 0.61 | 73.20 | 241,654 | — | ↗ |
| 2023-06-13 | Harris Todd | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 7,927 | 2.25 | 17.8K | 389,610 | — | ↗ |
| 2023-06-13 | Bensen Daniel | Officer | M-Exempt | D | Stock Option (Right to Buy) | 5,628 | 0.61 | 3.4K | 241,774 | — | ↗ |
| 2023-05-31 | Verjee Rehan | Director | A-Award | A | Stock Option (Right to Buy) | 14,500 | 14.47 | 209.8K | 14,500 | — | ↗ |
| 2023-05-31 | Subramony Siddarth | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 14,500 | 14.47 | 209.8K | 14,500 | — | ↗ |
| 2023-05-31 | Simson Jake | Director | A-Award | A | Stock Option (Right to Buy) | 14,500 | 14.47 | 209.8K | 14,500 | — | ↗ |
| 2023-05-31 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 14,500 | 14.47 | 209.8K | 14,500 | — | ↗ |
| 2023-05-31 | MORE ROBERT J | Director | A-Award | A | Stock Option (Right to Buy) | 14,500 | 14.47 | 209.8K | 14,500 | — | ↗ |
| 2023-05-31 | Kjellson Nina S | Director | A-Award | A | Stock Option (Right to Buy) | 14,500 | 14.47 | 209.8K | 14,500 | — | ↗ |
| 2023-05-31 | KAPLAN GILLA | Director | A-Award | A | Stock Option (Right to Buy) | 14,500 | 14.47 | 209.8K | 14,500 | — | ↗ |
| 2023-05-31 | CHEN ISAN | Director | A-Award | A | Stock Option (Right to Buy) | 14,500 | 14.47 | 209.8K | 14,500 | — | ↗ |
| 2023-04-03 | Harris Todd | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 2,000 | 2.25 | 4.5K | 397,537 | — | ↗ |
| 2023-04-03 | Bensen Daniel | Officer | M-Exempt | D | Stock Option (Right to Buy) | 2,000 | 0.61 | 1.2K | 229,421 | — | ↗ |
| 2023-03-31 | Harris Todd | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 500 | 2.25 | 1.1K | 399,537 | — | ↗ |
| 2023-03-31 | Bensen Daniel | Officer | M-Exempt | A | Common Stock | 400 | 0.61 | 244.00 | 528,381 | — | ↗ |
| 2023-03-30 | Harris Todd | Director / Officer | M-Exempt | A | Common Stock | 2,407 | 2.25 | 5.4K | 1,703,683 | — | ↗ |
| 2023-03-30 | Bensen Daniel | Officer | S-Sale | D | Common Stock | 2,000 | 16.01 | 32.0K | 527,981 | — | ↗ |
| 2023-03-29 | Harris Todd | Director / Officer | M-Exempt | A | Common Stock | 1,420 | 2.25 | 3.2K | 1,702,696 | — | ↗ |
| 2023-03-29 | Bensen Daniel | Officer | M-Exempt | D | Stock Option (Right to Buy) | 2,187 | 0.61 | 1.3K | 233,821 | — | ↗ |
| 2023-03-28 | Harris Todd | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 2,779 | 2.25 | 6.3K | 403,864 | — | ↗ |
| 2023-03-28 | Bensen Daniel | Officer | M-Exempt | A | Common Stock | 3,346 | 0.61 | 2.0K | 531,327 | — | ↗ |
| 2023-03-27 | Harris Todd | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 2,963 | 2.25 | 6.7K | 406,643 | — | ↗ |
| 2023-03-27 | Bensen Daniel | Officer | M-Exempt | A | Common Stock | 8,048 | 0.61 | 4.9K | 536,029 | — | ↗ |
| 2023-03-24 | Harris Todd | Director / Officer | M-Exempt | A | Common Stock | 170 | 2.25 | 382.50 | 1,701,446 | — | ↗ |
| 2023-03-23 | Harris Todd | Director / Officer | S-Sale | D | Common Stock | 2,800 | 16.00 | 44.8K | 1,701,276 | — | ↗ |
| 2023-03-23 | Bensen Daniel | Officer | M-Exempt | D | Stock Option (Right to Buy) | 4,827 | 0.61 | 2.9K | 247,402 | — | ↗ |
| 2023-03-22 | Harris Todd | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 4,043 | 2.25 | 9.1K | 412,576 | — | ↗ |
| 2023-03-22 | Bensen Daniel | Officer | M-Exempt | A | Common Stock | 3,800 | 0.61 | 2.3K | 531,781 | — | ↗ |
| 2023-03-21 | Harris Todd | Director / Officer | M-Exempt | D | Stock Option (Right to Buy) | 12,393 | 2.25 | 27.9K | 416,619 | — | ↗ |
| 2023-03-21 | Bensen Daniel | Officer | M-Exempt | A | Common Stock | 14,100 | 0.61 | 8.6K | 542,081 | — | ↗ |
| 2023-03-15 | Tada Hiroomi | Officer | A-Award | A | Common Stock | 1,893 | 6.58 | 12.5K | 83,130 | — | ↗ |
| 2023-03-15 | Harris Todd | Director / Officer | A-Award | A | Common Stock | 1,808 | 6.58 | 11.9K | 1,701,276 | — | ↗ |
| 2023-02-21 | Patel Piyush R. | Officer | G-Gift | D | Common Stock | 8,442 | 0.00 | — | 73,794 | — | ↗ |
| 2023-02-10 | MVA Investors, LLC | 10% Owner | S-Sale | D | Common Stock | 65,568 | 13.40 | 878.6K | 22,527 | — | ↗ |
| 2023-02-09 | MVA Investors, LLC | 10% Owner | S-Sale | D | Common Stock | 200,000 | 13.10 | 2.62M | 88,095 | — | ↗ |
| 2023-01-01 | Fuhrman Alan | Officer | A-Award | A | Stock Option (Right to Buy) | 32,800 | 0.00 | — | 32,800 | — | ↗ |
| 2022-10-12 | Patel Piyush R. | Officer | G-Gift | D | Common Stock | 56,276 | 0.00 | — | 82,236 | — | ↗ |
| 2022-09-15 | van den Boom Esther | Officer | A-Award | A | Common Stock | 1,452 | 7.66 | 11.1K | 121,897 | — | ↗ |
| 2022-09-15 | Tada Hiroomi | Officer | A-Award | A | Common Stock | 612 | 7.66 | 4.7K | 81,237 | — | ↗ |
| 2022-09-15 | Patel Piyush R. | Officer | A-Award | A | Common Stock | 1,040 | 7.66 | 8.0K | 138,512 | — | ↗ |
| 2022-09-15 | Hudkins Robert L. | Officer | A-Award | A | Common Stock | 1,040 | 7.66 | 8.0K | 273,576 | — | ↗ |
| 2022-09-06 | van den Boom Esther | Officer | A-Award | A | Stock Option (Right to Buy) | 105,000 | 0.00 | — | 105,000 | — | ↗ |
| 2022-09-06 | Tada Hiroomi | Officer | A-Award | A | Common Stock | 2,703 | 8.53 | 23.0K | 80,625 | — | ↗ |
| 2022-09-06 | Swanson Ronald V. | Officer | A-Award | A | Common Stock | 3,125 | 8.53 | 26.6K | 273,254 | — | ↗ |
| 2022-09-06 | Patel Piyush R. | Officer | A-Award | A | Stock Option (Right to Buy) | 30,924 | 0.00 | — | 30,924 | — | ↗ |
| 2022-09-06 | Hudkins Robert L. | Officer | A-Award | A | Common Stock | 2,408 | 8.53 | 20.5K | 272,536 | — | ↗ |
| 2022-09-06 | Harris Todd | Officer | A-Award | A | Common Stock | 3,125 | 8.53 | 26.6K | 1,699,468 | — | ↗ |
| 2022-09-06 | Bensen Daniel | Officer | A-Award | A | Stock Option (Right to Buy) | 249,532 | 0.00 | — | 249,532 | — | ↗ |
| 2022-06-13 | Verjee Rehan | Director | A-Award | A | Stock Option (Right to Buy) | 14,500 | 0.00 | — | 14,500 | — | ↗ |
| 2022-06-13 | Subramony Siddarth | Director | A-Award | A | Stock Option (Right to Buy) | 14,500 | 0.00 | — | 14,500 | — | ↗ |
| 2022-06-13 | Simson Jake | Director | A-Award | A | Stock Option (Right to Buy) | 14,500 | 0.00 | — | 14,500 | — | ↗ |
| 2022-06-13 | Shah Rajeev M. | Director | A-Award | A | Stock Option (Right to Buy) | 14,500 | 0.00 | — | 14,500 | — | ↗ |
| 2022-06-13 | RA CAPITAL MANAGEMENT, L.P. | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 14,500 | 5.38 | 78.0K | 14,500 | — | ↗ |
| 2022-06-13 | MORE ROBERT J | Director | A-Award | A | Stock Option (Right to Buy) | 14,500 | 0.00 | — | 14,500 | — | ↗ |
| 2022-06-13 | Kjellson Nina S | Director | A-Award | A | Stock Option (Right to Buy) | 14,500 | 0.00 | — | 14,500 | — | ↗ |
| 2022-06-13 | KAPLAN GILLA | Director | A-Award | A | Stock Option (Right to Buy) | 14,500 | 0.00 | — | 14,500 | — | ↗ |
| 2022-06-13 | CHEN ISAN | Director | A-Award | A | Stock Option (Right to Buy) | 14,500 | 5.38 | 78.0K | 14,500 | — | ↗ |
Executive team
Top executives
Shares Outstanding
53.71M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Todd Harris, Ph.D. Chief Executive Officer | 658.0K | — | — | 4.57M | 325.7K | 15.3K | 5.57M | 82.06% | ↗ |
| 2 | 2025 | Bhavesh Ashar Chief Operating Officer | 45.8K | — | — | 4.64M | — | 1.0K | 4.69M | 99.00% | ↗ |
| 3 | 2025 | Douglas Warner, M.D. Chief Medical Officer | 551.2K | — | — | 1.61M | 198.4K | 15.1K | 2.37M | 67.77% | ↗ |
| 4 | 2024 | Todd Harris, Ph.D. Chief Executive Officer | 632.7K | — | — | 6.50M | 433.4K | 950.00 | 7.57M | 85.90% | ↗ |
| 5 | 2024 | Douglas Warner, M.D. Chief Medical Officer | 165.6K | — | — | 4.47M | 90.5K | 313.00 | 4.73M | 94.57% | ↗ |
| 6 | 2024 | Daniel Bensen Chief Operating Officer | 475.9K | — | — | 1.92M | 260.8K | 950.00 | 2.66M | 72.22% | ↗ |
| 7 | 2023 | Todd Harris, Ph.D. Chief Executive Officer | 608.4K | — | — | 3.56M | 456.3K | 950.00 | 4.63M | 76.96% | ↗ |
| 8 | 2023 | Alan Fuhrman Chief Financial Officer | 457.6K | — | — | 2.77M | 274.6K | 30.9K | 3.53M | 78.39% | ↗ |
| 9 | 2023 | Hiroomi Tada, M.D., Ph.D. Chief Medical Officer | 509.6K | — | — | 1.60M | 305.8K | 950.00 | 2.41M | 66.16% | ↗ |
| 10 | 2023 | Daniel Bensen Chief Operating Officer | 457.6K | — | — | 1.19M | 274.6K | 950.00 | 1.92M | 61.82% | ↗ |
| 11 | 2022 | Ali Fawaz General Counsel | 275.0K | — | — | 2.13M | 193.6K | 23.1K | 2.62M | 81.27% | ↗ |
| 12 | 2022 | Daniel Bensen Chief Operating Officer | 436.3K | — | — | 1.80M | 193.6K | 950.00 | 2.43M | 74.04% | ↗ |
| 13 | 2022 | Todd Harris, Ph.D. Chief Executive Officer | 580.6K | — | — | 1.38M | 321.8K | 950.00 | 2.29M | 60.51% | ↗ |
| 14 | 2022 | Hiroomi Tada, M.D., Ph.D. Chief Medical Officer | 486.3K | — | — | 563.9K | 215.6K | 950.00 | 1.27M | 44.52% | ↗ |
| 15 | 2021 | Todd Harris, Ph.D. Chief Executive Officer | 442.8K | — | — | 5.76M | 168.9K | 986.00 | 6.38M | 90.39% | ↗ |
| 16 | 2021 | Ronald V. Swanson, Ph.D. Chief Scientific Officer | 432.3K | — | — | 1.99M | 103.0K | 921.00 | 2.53M | 78.79% | ↗ |
| 17 | 2021 | Hiroomi Tada, M.D., Ph.D. Chief Medical Officer | 403.8K | — | — | 1.99M | 114.7K | 1.1K | 2.51M | 79.31% | ↗ |
| 18 | 2021 | Daniel Bensen Chief Operating Officer | 355.1K | — | — | 1.99M | 103.0K | 1.0K | 2.45M | 81.27% | ↗ |
| 19 | 2020 | Todd Harris, Ph.D. Chief Executive Officer | 350.2K | — | 677.5K | — | 210.1K | 1.0K | 1.24M | 54.69% | ↗ |
| 20 | 2020 | Ronald V. Swanson, Ph.D. Chief Scientific Officer | 246.8K | — | — | 128.3K | 111.0K | 900.00 | 487.0K | 26.34% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Todd Harris | Co-Founder, CEO, President & Director | 999.0K | — |
| Douglas Warner | Chief Medical Officer | 764.7K | — |
| Alan Fuhrman | Chief Financial Officer | 763.1K | male |
| Daniel Bensen | Co-Founder & Chief Discovery Officer | 737.6K | male |
| Ali D. Fawaz | General Counsel & Secretary | 629.2K | male |
| Bhavesh Ashar | Chief Operating Officer | 551.0K | male |
| Ronald V. Swanson | Chief Scientific Officer | 536.2K | — |
| Liz Pagano | Chief Human Resources Officer | — | — |
| Ralph William Charlton | Senior Vice President of Clinical Development | — | — |
| Erik Goluboff | Senior Vice President of Clinical Development | — | male |
| Sarah Honig | Senior Vice President of Corporate Development & Strategy | — | female |
| Robert L. Hudkins | Chief Technology Officer | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TYRA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
